Fahmi Quadir is a founder and manager of Saftkhet Capital Management, a short-only hedge fund focused on fraud identification and deep forensic research.

Previously, Quadir worked as an Equity Analyst at Krensavage Asset Management where she played a pivotal role among investors successfully shorting Valeant Pharmaceuticals. Prior to her position at Krensavage, Quadir worked at Deallus Consulting as an Analyst and worked her way up to Senior Associate.

While attending school, Quadir was a New York Academy of Sciences Fellow at the Maimonides Medical Center, James Simons Fellow at the Stony Brook University Medical Center, a Researcher at Harvey Mudd College, and Strauss Research Fellow at ICDDR, B. She was also chosen to the Forbes 30 Under 30​ list for 2018 in the Finance category.

Quadir attended Harvey Mudd College​ where she participated in many organizations including Claremont Peace & Justice, Mudders Making a Difference, Association for Women in Mathematics, Association for the Advancement of Science, and Concert Choir. She graduated in 2012 with degrees in Mathematics​ and Biology​.

Hedge Funds, Investing, Capital Markets, Capital Budgeting, Finance, Business, Business Leadership, Business Growth, Women in Leadership, Women in Business, Fraud, Researcher, Research & Exploration, Leadership, Economy Science,